eBay Inc vs Novavax Inc — how do they compare? eBay Inc trades at $112.73 (market cap $50.07B), while Novavax Inc trades at $8.27 (market cap $1.39B). The key difference: eBay Inc is far larger — about 36× Novavax Inc's market cap, and eBay Inc pays a 1.1% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| EBAY | NVAX | |
|---|---|---|
Market Cap | $50.07B | $1.39B |
Volume | 5,186,418 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $118.96 | $11.19 |
52-Week Low | $76.79 | $6.22 |
Enterprise Value | $53.41B | $890.94M |
Dividend Yield | 1.1% | — |
Signals from Pluang's Aura AI — not financial advice
EBAY trades at $112.54, down 2.22% today, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong earnings beats in recent quarters with Q1 2026 EPS of $1.66 beating expectations of $1.58. Revenue growth accelerated to $11.1B in 2025, while maintaining robust profitability with 71.79% gross margins and 17.61% net income margin. Recent developments include the UK regulator clearing eBay's acquisition of Depop and ongoing market speculation about GameStop's takeover interest.
EBAY presents a mixed investment case with strong fundamentals offset by acquisition uncertainty. The stock trades above analyst consensus target of $108.78 despite recent weakness. Key opportunities include continued earnings momentum and advertising revenue growth, while risks center on competitive pressures and potential takeover volatility. Institutional sentiment remains cautiously optimistic with 46% buy ratings.
Novavax (NVAX) trades at $8.42, down 5.5% on the day, reflecting a bearish technical trend. Despite a low P/E of 3.14 and recent earnings beats, the company reported a net loss margin of -14.73% for 2026 and negative cash flows. Analyst consensus is a 'Buy' with a $14.00 price target, but technical indicators signal selling pressure. Recent news highlights stock volatility and shareholder dissent at the AGM.
The outlook is mixed: strong valuation ratios and earnings beats offer upside potential, but persistent negative cash flow, high debt, and competitive pressures pose significant risks. Investor sentiment is cautious amid bearish technical signals and uncertain revenue sustainability beyond 2025.
Trailing returns across standard periods
Latest headlines on both assets
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →